Association of Southwest German Radiologists and Nuclear Medicine Specialists
From Theory to Practice: Evaluating g-values within mint Lesion
Following the FDA’s recent analysis of the growth rate constant (g) as a prognostic marker1, the challenge for many research organizations is…
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Update RSNA: Heart and Lung Imaging
01/09
to
01/10/2026
Cologne, Germany
Seminar in Radiological Diagnostics: "RSNA Update – Heart and Lung Imaging"
LMU University Hospital: Artificial Intelligence for TNM Staging in NSCLC – How Reliable Are AI-Based Segmentations?
The recent study “Artificial intelligence for TNM staging in NSCLC – a critical appraisal of segmentation utility in [¹⁸F]FDG PET/CT” provides a…
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
RSNA 2025
11/30
to
12/03/2025
Chicago, Illinois
Annual Meeting of the Radiological Society of North America
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
BioPharma Clinical Trials Nexus
11/18
to
11/19/2025
Parsippany-Troy Hills, NJ
24th BioPharma Clinical Trials Nexus
About Cookies
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.
